Bizseer Consultants , Pune

Honda India thrives on exports in May 2024; struggles with domestic sales   Honda India faced contrasting fortunes in May 2024. While the brand reported overall sales of 11,343 units, including exports, the domestic market posed challenges. Out of the total sales, more than 6,500 cars were exported, including the locally manufactured Elevate (sold as the WR-V in Japan). The ongoing heat wave across the country led to weaker showroom footfall, affecting the domestic market. Honda India remains optimistic about improved conditions in the coming months, but it faces stiff competition from segment-leading models like the Maruti Suzuki Dzire and Hyundai Creta. The Amaze compact sedan and the Elevate crossover are key players for Honda India's market share growth.   For more details on this news article, pl visit the URL below   The original article can be found on –   https://www.carwale.com/news/honda-india-exports-over-6500-cars-in-may-2024-struggles-with-domestic-sales...

Pharma exports to grow at a faster clip, touch $31 billion in FY25   India's pharmaceutical exports are poised for remarkable growth, with expectations to surpass $31 billion in FY25. This surge is driven by several factors, notably a shortage of drugs in the crucial U.S. market. The Pharmaceuticals Export Promotion Council of India predicts an 11% growth rate for the industry. In the fiscal year ending March 2024, pharma exports reached $27.8 billion, despite global challenges. Over 50% of these exports were to highly regulated markets in North America and Europe. The Indian pharmaceutical industry's commitment to quality and affordability positions it for continued success.     For more details on this news article, pl visit the URL below   The original article can be found on –   https://www.thehindu.com/business/Industry/pharma-exports-to-grow-at-a-faster-clip-touch-31-bn-in-fy25/article68233592.ece   Please note that the credit fo...